<p>Clinical pathological and immunohistochemical findings in colorectal cancer cases with novel KRAS mutations.</p
KRAS-mutated carcinomas comprise 35-40% of all colorectal carcinomas but little is known about their...
Introduction: Despite the important role of general KRAS mutational status in the selection of an ad...
<p>Baseline and clinical characteristics of colorectal cancer cases by <i>KRAS</i> and <i>BRAF</i> m...
<p>Clinical, pathological and immunohistochemical findings in colorectal cancer cases with novel K-r...
<p>Clinical, pathological and immunohistochemical findings in colorectal cancer cases with novel K-r...
KRAS mutation in adenoma and carcinoma components and clinicopathologic features.</p
Background: KRAS mutations have a significant role in the consecutive activation of RAS-RAF-MEK-ERK ...
In this article, we report 7 novel KRAS gene mutations discovered while retrospectively studying the...
Aim: The purpose of this study was to estimate the prevalence of KRAS mutations in stage IV colorect...
Somatic mutations in the KRAS gene often occur in colorectal cancer (CRC) and are predictive for poo...
OBJECTIVE: KRAS and mismatch repair genes are two important molecular markers used in determining pr...
homologue) gene plays an important role in colorectal tumorigenesis. This study examined association...
10.1007/s00384-010-1097-0International Journal of Colorectal Disease2681083-1084IJCD
Aim of study: to identify distribution patterns of KRAS and NRAS genes mutations in colorectal carci...
KRAS mutation analysis should be performed before initiating anti-EGFR therapy in patients with meta...
KRAS-mutated carcinomas comprise 35-40% of all colorectal carcinomas but little is known about their...
Introduction: Despite the important role of general KRAS mutational status in the selection of an ad...
<p>Baseline and clinical characteristics of colorectal cancer cases by <i>KRAS</i> and <i>BRAF</i> m...
<p>Clinical, pathological and immunohistochemical findings in colorectal cancer cases with novel K-r...
<p>Clinical, pathological and immunohistochemical findings in colorectal cancer cases with novel K-r...
KRAS mutation in adenoma and carcinoma components and clinicopathologic features.</p
Background: KRAS mutations have a significant role in the consecutive activation of RAS-RAF-MEK-ERK ...
In this article, we report 7 novel KRAS gene mutations discovered while retrospectively studying the...
Aim: The purpose of this study was to estimate the prevalence of KRAS mutations in stage IV colorect...
Somatic mutations in the KRAS gene often occur in colorectal cancer (CRC) and are predictive for poo...
OBJECTIVE: KRAS and mismatch repair genes are two important molecular markers used in determining pr...
homologue) gene plays an important role in colorectal tumorigenesis. This study examined association...
10.1007/s00384-010-1097-0International Journal of Colorectal Disease2681083-1084IJCD
Aim of study: to identify distribution patterns of KRAS and NRAS genes mutations in colorectal carci...
KRAS mutation analysis should be performed before initiating anti-EGFR therapy in patients with meta...
KRAS-mutated carcinomas comprise 35-40% of all colorectal carcinomas but little is known about their...
Introduction: Despite the important role of general KRAS mutational status in the selection of an ad...
<p>Baseline and clinical characteristics of colorectal cancer cases by <i>KRAS</i> and <i>BRAF</i> m...